3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Specimen Handling
195
Magnetic Resonance Spectroscopy
148
Biopsy
119
pembrolizumab
90
Carboplatin
81
Cisplatin
74
Nivolumab
72
Cyclophosphamide
65
Paclitaxel
61
Gemcitabine
49
Radiotherapy
47
Bevacizumab
43
Dexamethasone
39
durvalumab
36
venetoclax
34
Fluorouracil
34
atezolizumab
33
Pemetrexed
32
Injections
32
Capecitabine
32
Doxorubicin
31
olaparib
30
Rituximab
30
Radiation
28
Oxaliplatin
28
Lenalidomide
28
Prednisone
27
Etoposide
27
fludarabine
26
X-Rays
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Azathioprine
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled